Published in J Med Genet on February 16, 2007
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol (2013) 1.09
JAK2V617F mutation in patients with splanchnic vein thrombosis. Dig Dis Sci (2009) 0.89
Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.75
Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study. J Res Med Sci (2015) 0.75
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet (2005) 18.59
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature (2005) 18.43
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell (2005) 17.41
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (2000) 3.16
Polycythemia vera: myths, mechanisms, and management. Blood (2002) 3.01
Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood (1996) 2.02
Inherited thrombophilia: Part 1. Thromb Haemost (1996) 2.00
The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med (1994) 1.96
Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost (2005) 1.95
Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest (2000) 1.60
Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Thromb Haemost (1996) 1.58
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology (2006) 1.51
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost (2006) 1.37
Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2. Blood (2005) 1.31
Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood (1994) 1.27
Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med (1998) 1.20
Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology (2005) 1.17
The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost (1998) 1.13
Current trends in essential thrombocythaemia. Br J Haematol (2002) 0.96
Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol (2002) 0.96
Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis (2002) 0.85
Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Thromb Haemost (2005) 0.85
Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med (2012) 10.64
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Authors' response to the letter of Nagirnaja et al., "Response to annexin A5 haplotype M2 is not a risk factor for recurrent miscarriages in Northern Europe, is there sufficient evidence?". Reprod Biomed Online (2016) 4.98
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood (2004) 4.70
Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet (2011) 3.68
Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol (2006) 2.70
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. Gastroenterology (2007) 2.32
Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance. Liver Int (2013) 2.07
Thrombophilic mutations are a main risk factor for placental abruption. Haematologica (2003) 1.65
Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics. Liver Int (2005) 1.63
Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol (2004) 1.62
Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation: an 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia. Thromb Haemost (2005) 1.50
Mutation analysis in hyperphenylalaninemia patients from South Italy. Clin Biochem (2013) 1.44
Clinical relevance of inherited thrombophilia in implantation failure: who needs to be screened? Haematologica (2003) 1.42
Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol (2010) 1.35
MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol (2005) 1.33
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis. Blood (2012) 1.31
The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors. Am J Gastroenterol (2012) 1.16
Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol (2007) 1.13
Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin. Haematologica (2004) 1.12
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention. Am J Hematol (2009) 1.11
The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression. Nephrol Dial Transplant (2002) 1.08
Impact of prothrombotic mutations and family history on the occurrence of intra-uterine fetal deaths. Haematologica (2002) 0.99
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease. Pharmacogenet Genomics (2011) 0.95
The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia. Blood Coagul Fibrinolysis (2006) 0.94
Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene. Mol Vis (2009) 0.93
Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications. Thromb Haemost (2009) 0.91
Population genetics of venous thromboembolism. A narrative review. Thromb Haemost (2010) 0.91
The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype. Haematologica (2008) 0.91
Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study. Hum Mutat (2005) 0.90
Clinical utility of screening for CALR gene exon 9 mutations in patients with splanchnic venous thrombosis. Thromb Haemost (2015) 0.89
Inherited platelet disorders: thrombocytopenias and thrombocytopathies. Blood Transfus (2009) 0.89
Eosinophilia and thrombophilia in churg strauss syndrome: a clinical and pathogenetic overview. Clin Appl Thromb Hemost (2009) 0.89
Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol (2008) 0.89
Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA). Mol Genet Metab (2008) 0.87
Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost (2002) 0.86
Adverse pregnancy outcomes are associated with multiple maternal thrombophilic factors. Eur J Obstet Gynecol Reprod Biol (2004) 0.86
Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome. Blood Coagul Fibrinolysis (2008) 0.85
PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. Nephrol Dial Transplant (2003) 0.85
Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study. Atherosclerosis (2009) 0.85
Polymorphic changes in the 5' flanking region of factor VII have a combined effect on promoter strength. Thromb Haemost (2002) 0.84
Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2. Fertil Steril (2008) 0.84
Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurobiol Aging (2003) 0.84
A novel CISD2 intragenic deletion, optic neuropathy and platelet aggregation defect in Wolfram syndrome type 2. BMC Med Genet (2014) 0.83
Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res (2009) 0.83
Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc Dis (2003) 0.83
The spectrum of subclinical Best vitelliform macular dystrophy in subjects with mutations in BEST1 gene. Invest Ophthalmol Vis Sci (2011) 0.83
Sex modulation of the occurrence of jak2 v617f mutation in patients with splanchnic venous thrombosis. Thromb Res (2011) 0.83
Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagul Fibrinolysis (2008) 0.83
Gene polymorphisms and sport attitude in Italian athletes. Genet Test Mol Biomarkers (2011) 0.83
The C677T methylenetetrahydrofolate reductase gene mutation does not influence cardiovascular risk in the dialysis population: results of a multicentre prospective study. Nephrol Dial Transplant (2004) 0.83
TET2 mutations in Ph-negative myeloproliferative neoplasms: identification of three novel mutations and relationship with clinical and laboratory findings. Biomed Res Int (2013) 0.82
Congenital nephrotic syndrome of Finnish type: detection of new nephrin mutations and prenatal diagnosis in an Italian family. Prenat Diagn (2005) 0.82
A novel mutation of gene CBFA1/RUNX2 in cleidocranial dysplasia. Ann Clin Lab Sci (2007) 0.82
Subclinical atherosclerosis in primary antiphospholipid syndrome. Ann N Y Acad Sci (2007) 0.82
Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group. Blood Coagul Fibrinolysis (2006) 0.82
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study. Thromb Haemost (2004) 0.81
Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost (2004) 0.81